Botanical species · safety record

Asparagus officinalis

The EFSA Compendium of Botanicals holds 7 constituent measurements for Asparagus officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Asparagus officinalis L.

7Constituent measurements
0Safety records
5Cited sources
91Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 91 licensed products naming Asparagus officinalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Aerial parts
  • Asparagus officinalis - Shoot
  • Flower
  • Fresh young underground shoots
  • Jeunes pousses
  • Root
  • Shoot
  • Shoots

What the records describe

Constituents measured

  • Protodioscin4
  • Steroidal saponins2
  • Saponins1

Plant parts

  • Live plants3
  • Aerial part of plants2
  • Roots and other underground parts1
  • Unspecified1

Preparations

  • Solvent extraction7

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ProtodioscinLive plantsSolvent extraction≤ 4.83 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
ProtodioscinLive plantsSolvent extraction≥ 1.5 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
ProtodioscinAerial part of plantsSolvent extraction≤ 21.3 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
ProtodioscinAerial part of plantsSolvent extraction≥ 1 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
SaponinsUnspecifiedSolvent extraction0.1604 Microgram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Steroidal saponinsRoots and other underground partsSolvent extractionHPLC with standard detection methodsResolve DOI
Steroidal saponinsLive plantsSolvent extractionUnspecifiedResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Lee, Eun Jin., Yoo, Kil Sun., Patil, Bhimanagouda S. Development of a Rapid HPLC-UV Method for Simultaneous Quantification of Protodioscin and Rutin in White and Green Asparagus Spears . Journal of food science, 2010, vol. 75, no. 9, p. C703-C709. DOI
  2. Huang, Xue-Feng., Lin, Yu-Ying., Kong, Ling-Yi. Steroids from the roots of Asparagus officinalis and their cytotoxic activity . Journal of integrative plant biology, 2008, vol. 50, no. 6, p. 717-722. DOI
  3. Kronabel, D. Antileukemic effectiveness of saponins and sapogenins from Asparagus officinalis L. Antileuk�misch wirksame Saponine und Sapogenine aus Asparagus officinalis L . Deutsche zeitschrift fur onkologie, 2014, vol. 46, no. 2, p. 62-65. DOI
  4. Motoki, Satoru., Kitazawa, Hiroaki., Maeda, Tomoo., Suzuki, Takashi., Chiji, Hideyuki., Nishihara, Eiji., Shinohara, Yutaka. Effects of Various Asparagus Production Methods on Rutin and Protodioscin Contents in Spears and Cladophylls . Bioscience biotechnology and biochemistry, 2012, vol. 76, no. 5, p. 1047-1050. DOI
  5. Dou, Fang., Xi, Miaomiao., Wang, Junxian., Tian, Xiangrong., Hong, Liangjian., Tang, Haifeng., Wen, Aidong. alpha-Glucosidase and alpha-amylase inhibitory activities of saponins from traditional Chinese medicines in the treatment of diabetes mellitus. PHARMAZIE, 2013, vol. 68, no. 4, p. 300-304. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue